MAPK/ERK kinase inhibitors

Details for Australian Patent Application No. 2007337003 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Dong, Qing; Scorah, Nicholas; Kaldor, Stephen W.; Zhou, Feng; Kanouni, Toufike; Wallace, Michael B.; Gong, Xianchang

Agent Griffith Hack

Pub. Number AU-A-2007337003

PCT Pub. Number WO2008/079814

Priority 60/870,913 20.12.06 US

Filing date 18 December 2007

Wipo publication date 3 July 2008

International Classifications

A61K 31/4375 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

23 July 2009 PCT application entered the National Phase

  PCT publication WO2008/079814 Priority application(s): WO2008/079814

30 July 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 03 Jul 2009

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007337004-Method and system for promoting longevity and healthy vitality of a pet

2007336963-Method of controlling a rail transport system for conveying bulk materials